Peptidylarginine deiminase 4 overexpression resensitizes MCF-7/ADR breast cancer cells to adriamycin via GSK3β/p53 activation.

Peptidylarginine deiminase 4 overexpression resensitizes MCF-7/ADR breast cancer cells to adriamycin via GSK3β/p53 activation. — المؤلف: Zhou, Qianqian — Cancer management and research 2019

المؤلف
Zhou, Qianqian
النشر
Cancer management and research 2019
الوصف
625-636 p.